Ratios	Mar2014	Jun2014	Sep2014	Dec2014	Mar2015	Jun2015	Sep2015	Dec2015	Mar2016	Jun2016	Sep2016	Dec2016	Mar2017	Jun2017	Sep2017	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026

Rocket Pharmaceuticals Ratios (2014-2026) | RCKT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Mar2014	Jun2014	Sep2014	Dec2014	Mar2015	Jun2015	Sep2015	Dec2015	Mar2016	Jun2016	Sep2016	Dec2016	Mar2017	Jun2017	Sep2017	Dec2017	Mar2018	Jun2018	Sep2018	Dec2018	Mar2019	Jun2019	Sep2019	Dec2019	Mar2020	Jun2020	Sep2020	Dec2020	Mar2021	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Efficiency
Assets Average (Quarter)																														555.82M	532.70M	513.63M	478.58M	446.00M	424.56M	484.54M	533.28M	488.27M	530.27M	582.55M	532.89M	472.93M	420.05M	460.69M	499.38M	446.02M	394.51M	349.24M	307.93M
Equity Average (Quarter)																														484.72M	487.55M	470.19M	436.17M	402.66M	377.50M	428.50M	474.28M	430.92M	472.03M	516.83M	467.04M	413.07M	357.20M	396.50M	437.69M	383.17M	333.94M	295.44M	257.63M
Invested Capital (Quarter)																														489.44M	485.66M	454.72M	417.62M	387.70M	367.31M	489.69M	458.88M	402.97M	541.09M	492.57M	441.50M	384.63M	329.77M	463.23M	412.14M	354.21M	313.67M	277.22M	238.04M
Leverage & Solvency
Interest Coverage Ratio (Quarter)																														-135.65	-92.97	-95.75	-91.73	-116.58	-125.78	-147.93	-132.89	-146.92	-139.51	-134.64	-143.05	-156.50	-147.40	-132.55	-136.42	-150.42	-110.46	-92.95	-102.56
Debt to Equity (Quarter)
Debt Ratio (Quarter)
Equity Ratio (Quarter)																														0.91	0.92	0.91	0.91	0.90	0.88	0.89	0.89	0.87	0.90	0.87	0.88	0.86	0.84	0.88	0.87	0.84	0.85	0.84	0.83
Times Interest Earned (Quarter)																														-135.65	-92.97	-95.75	-91.73	-116.58	-125.78	-147.93	-132.89	-146.92	-139.51	-134.64	-143.05	-156.50	-147.40	-132.55	-136.42	-150.42	-110.46	-92.95	-102.56
Valuation
Enterprise Value (Quarter)																														-589.02M	-421.46M	-388.74M	-562.64M	-321.37M	-416.37M	-356.39M	-626.50M	-568.96M	-437.17M	-373.18M	-330.31M	-278.82M	-235.66M	-372.34M	-318.16M	-510.18M	-222.76M	-188.93M	-239.17M
Return Ratios
Return on Capital Employed (Quarter)																														-30.15%	-35.84%	-34.03%	-37.41%	-45.23%	-50.61%	-50.37%	-48.59%	-56.95%	-53.43%	-48.62%	-52.97%	-61.97%	-72.04%	-65.05%	-58.23%	-66.48%	-68.94%	-72.64%	-76.15%
Return on Assets (Quarter)																														0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%
Return on Equity (Quarter)																														0.00%	0.00%	0.00%	0.00%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	0.00%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%	-0.01%